Radnostix, Inc. (INIS)
OTCMKTS · Delayed Price · Currency is USD
0.0700
+0.0100 (16.67%)
Jan 8, 2026, 4:00 PM EST
Radnostix Market Cap
Radnostix has a market cap or net worth of $34.33 million as of January 9, 2026. Its market cap has increased by 98.12% in one year.
Market Cap
34.33M
Enterprise Value
41.49M
Revenue
14.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since September 29, 1997, Radnostix's market cap has decreased from 60.40M to 34.33M, a decrease of -43.15%. That is a compound annual growth rate of -1.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 34.33M | 6.12% |
| Dec 31, 2025 | 32.35M | 79.64% |
| Dec 31, 2024 | 18.01M | -13.38% |
| Dec 29, 2023 | 20.79M | 24.25% |
| Dec 30, 2022 | 16.73M | -64.57% |
| Dec 31, 2021 | 47.23M | 118.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 506.04M |
| Northwest Biotherapeutics | 405.74M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 352.88M |
| Silence Therapeutics | 273.96M |